SEARCH

SEARCH BY CITATION

References

  • Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M. and Fukami Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 55925595.
  • Apparsundaram S., Sung U., Price R. D. and Blakely R. D. (2001) Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J. Pharmacol. Exp. Ther. 299, 666677.
  • Bannon M. J. (2005) The dopamine transporter: role in neurotoxicity and human disease. Toxicol. App. Pharmacol. 204, 355360.
  • Beckman M. L., Bernstein E. M. and Quick M. W. (1998) Protein Kinase C regulates the interaction between a GABA transporter and syntaxin 1A. J. Neurosci. 18, 61036112.
  • Blochl A. and Sirrenberg C. (1996) Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via trk and p75lntr receptors. J. Biol. Chem. 271, 2110021107.
  • Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • Carvelli L., Moron J. A., Kahlig K. M. et al. (2002) PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81, 859869.
  • Chi L. and Reith M. E. A. (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J. Pharmacol. Exp. Ther. 307, 729736.
  • Corrodi H. and Fuxe K. (1967) The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition. Life Sci. 6, 13451350.
  • Daniels G. M. and Amara S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 3579435801.
  • Dluzen D. E., Gao X., Story G. M., Anderson L. I., Kucera J. and Walro J. M. (2001) Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp. Neurol. 170, 121128.
  • Doolen S. and Zahniser N. R. (2001) Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J. Pharmacol. Exp. Ther. 296, 931938.
  • Dunnett S. B. and Bjorklund A. (1992) Staging and dissection of rat embryos, in Neural Transplantation: A Practical Approach, (DunnettS. B. and BjorklundA., eds), pp. 1115. IRL Press, New York.
  • Feng L., Wang C.-Y., Jiang H., Oho C., Dugich-Djordjevic M., Mei L. and Lu B. (1999) Differential signaling of glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor in cultured ventral mesencephalic neurons. Neurosci. 93, 265273.
  • Figlewicz D. P., Evans S. B., Murphy J., Hoen M. and Baskin D. G. (2003) Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. 964, 107115.
  • Foster J. D., Cervinski M A., Gorentla B. K. and Vaughan R. A. (2006) Regulation of the dopamine transporter by phosphorylation. Handb. Exp. Pharmacol. 175, 197214.
  • Garcia B. G., Wei Y., Moron J. A., Lin R. Z., Javitch J. A. and Galli A. (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol. Pharmacol. 68, 102109.
  • Gether U., Andersen P. H., Larsson O. M. and Schousboe A. (2006) Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27, 375383.
  • Gil C., Najib A. and Aguilera J. (2003) Serotonin transport is modulated differently by tetanus toxin and growth factors. Neurochem. Int. 42, 535542.
  • Goggi J., Pullar I. A., Carney S. L. and Bradford H. F. (2003) Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res. 968, 156161.
  • Goldberg D. J. and Wu D. Y. (1995) Inhibition of formation of filopodia after axotomy by inhibitors of protein tyrosine kinases. J. Neurobiol. 27, 553560.
  • Grimm J. W., Lu L., Hayashi T., Hope B. T., Su T.-P. and Shaham Y. (2003) Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 23, 742747.
  • Gulley J. M. and Zahniser N. R. (2003) Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. E. J. Pharmacol. 479, 139152.
  • Hall F. S., Drgonova J., Goeb M. and Uhl G. R. (2003) Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28, 14851490.
  • Horger B. A., Iyasere C. A., Berhow M. T., Messer C. J., Nestler E. J. and Taylor J. R. (1999) Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19, 41104122.
  • Huang E. J. and Reichardt L. F. (2003) Trk receptors: roles in neuronal signal transduction. Ann. Rev. Biochem. 72, 609642.
  • Hyman C., Juhasz M., Jackson C., Wright P., Ip N. and Lindsay R. (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14, 335347.
  • Knusel B., Winslow J., Rosenthal A., Burton L., Seid D., Nikolics K. and Hefti F. (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl Acad. Sci. USA 88, 961965.
  • Kuiper G. G. J. M., Lemmen J. G., Carlsson B., Corton J. C., Safe S. H., Van Der Saag P. T., Van Der Burg B. and Gustafsson J.-A. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 42524263.
  • Law R. M., Stafford A. and Quick M. W. (2000) Functional regulation of gamma-aminobutyric acid transporters by direct tyrosine phosphorylation. J. Biol. Chem. 275, 2398623991.
  • Licata S. C. and Pierce R. C. (2003) The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization. J. Neurochem. 85, 1422.
  • Lin Z., Zhang P.-W., Zhu X., Melgari J.-M., Huff R., Spieldoch R. L. and Uhl G. R. (2003) Phosphatidylinositol 3-kinase, protein kinase C, and MEK1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites. J. Biol. Chem. 278, 2016220170.
  • Linford N. J., Yang Y., Cook D. G. and Dorsa D. M. (2001) Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 299, 6775.
  • Marshall J. F. (1978) Further analysis of the resistance of the diabetic rat to d-amphetamine. Pharmacol. Biochem. Behav. 8, 281286.
  • Melikian H. E. (2004) Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol. Ther. 104, 1727.
  • Miranda M., Wu C. C., Sorkina T., Korstjens D. R. and Sorkin A. (2005) Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C. J. Biol. Chem. 280, 35 61735 624.
  • Moron J. A., Zakharova I., Ferrer J. V. et al. (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 23, 84808488.
  • Mossner R., Daniel S., Albert D., Heils A., Okladnova O., Schmitt A. and Lesch K.-P. (2000) Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem. Int. 36, 197202.
  • Nirenberg M., Vaughan R., Uhl G., Kuhar M. and Pickel V. (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16, 436447.
  • Numan S. and Seroogy K. B. (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403, 295308.
  • Owens W. A., Sevak R. J., Galici R., Chang X., Javors M. A., Galli A., France C. P. and Daws L. C. (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J. Neurochem. 94, 14021410.
  • Poo M.-M. (2001) Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2, 2432.
  • Prasad P. D., Torres-Zamorano V., Kekuda R., Leibach F. H. and Ganapathy V. (1997) Functional link between tyrosine phosphorylation and human serotonin transporter gene expression. E. J. Pharmacol. 325, 8592.
  • Prochiantz A., Daguet M. C., Herbet A. and Glowinski J. (1981) Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurones by striatal membranes. Nature 293, 570572.
  • Pu L., Liu Q.-S. and Poo M.-M. (2006) BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat. Neurosci. 9, 605607.
  • Quick M. W., Hu J., Wang D. and Zhang H.-Y. (2004) Regulation of a γ-aminobutyric acid transporter by reciprocal tyrosine and serine phosphorylation. J. Biol. Chem. 279, 1596115967.
  • Samuvel D. J., Jayanthi L. D., Bhat N. R. and Ramamoorthy S. (2005) A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J. Neurosci. 25, 2941.
  • Schinelli S., Paolillo M., Quartieri M. and Santagostino G. (1993) Dopamine synthesis, uptake and metabolism in embryonic rat mesencephalic cultures. Pharmacol. Res. 28, 265276.
  • Seroogy K. B., Lundgren K. H., Tran T. M., Guthrie K. M., Isackson P. J. and Gall C. M. (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342, 321334.
  • Shen R., Altar C. and Chiodo L. (1994) Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc. Natl Acad. Sci. USA 91, 89208924.
  • Simon J. R., Bare D. J., Ghetti B. and Richter J. A. (1997) A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum. Neurosci. Lett. 224, 201205.
  • Sorkina T., Hoover B. R., Zahniser N. R. and Sorkin A. (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6, 157170.
  • Sorkina T., Miranda M., Dionne K. R., Hoover B. R., Zahniser N. R. and Sorkin A. (2006) RNA interference screen reveals an essential role of NEDD4-2 in dopamine transporter ubiquitination and endocytosis. J. Neurosci. 26, 81958205.
  • Sweatt J. D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 110.
  • Torres G. E., Gainetdinov R. R. and Caron M. G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 1325.
  • Zahniser N. R. and Doolen S. (2001) Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 2155.
  • Zahniser N. R. and Sorkin A. (2004) Rapid regulation of the dopamine transporter: role in stimulant addiction? Neuropharmacol. 47 Suppl 1, 8091.
  • Zhu C.-B., Carneiro A. M., Dostmann W. R., Hewlett W. A. and Blakely R. D. (2005a) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J. Biol. Chem. 280, 1564915658.
  • Zhu J., Apparsundaram S., Bardo M. T. and Dwoskin L. P. (2005b) Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. J. Neurochem. 93, 14341443.